Nicholas J. Gross

机构：Teva Pharmaceuticals (United States) · ORCID：0000-0001-6231-8151

发表论文 224 篇 · 总被引 7642 次 · h-index 44

代表论文

• The mode of action of anticholinergics in asthma (2018 · European Respiratory Journal · 被引 142)
• Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study (2018 · The Lancet Neurology · 被引 111)
• New Therapies for Asthma and Chronic Obstructive Pulmonary Disease (2017 · American Journal of Respiratory and Critical Care Medicine · 被引 103)
• Quantification of Motor Function in Huntington Disease Patients Using Wearable Sensor Devices (2019 · Digital Biomarkers · 被引 42)
• The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study (2022 · CNS Drugs · 被引 33)
• Safety and Tolerability of Inhaled Loxapine in Subjects with Asthma and Chronic Obstructive Pulmonary Disease—Two Randomized Controlled Trials (2014 · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 被引 28)